Quick Answer
RESMED INC reported Revenue (ASC 606) of $5.15 billion for fiscal year 2025.
RESMED INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $5.15B | +9.8% |
| 2024 | $4.69B | +10.9% |
| 2023 | $4.22B | +18.0% |
| 2022 | $3.58B | +11.9% |
| 2021 | $3.20B | +8.1% |
| 2020 | $2.96B | +13.4% |
| 2019 | $2.61B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $1.42B | +11.0% | +6.5% |
| September 30, 2025 | $1.34B | +9.1% | +3.4% |
| March 31, 2025 | $1.29B | +7.9% | +0.8% |
| December 31, 2024 | $1.28B | +10.3% | +4.7% |
| September 30, 2024 | $1.22B | +11.1% | +2.3% |
| March 31, 2024 | $1.20B | +7.2% | +2.9% |
| December 31, 2023 | $1.16B | +12.5% | +5.5% |
| September 30, 2023 | $1.10B | +16.0% | -1.3% |
- RESMED INC showed an increase of +9.8% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2019–2025 period, RESMED INC’s revenue (asc 606) has grown by 97.4% (from $2.61 billion to $5.15 billion).
- The most recent figure is from RESMED INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: